Find Docs

Biosis - H2 BPRN (Page 30)

Wodocs >> Science : Biology >> Biosis H2 BPRN Page 30
Biosis - H2 BPRN
DIMDI Sample Record
N D :
97119294 BASE: BA70
S E C :
Biological Abstracts Vol. 097 Iss. 006 Ref. 069169
A U :
Farci P; Mandas A; Coiana A; Lai ME; Desmet V; Van Eyken P; Gobi Y; Caruso L; Scaccabarozzi S;
et al
T I :
Treatment of chronic hepatitis D with interferon alfa-2a.
S O :
New England Journal of Medicine, 330 (2). 1994. 88-94. /1994/
I S S N : 0 0 2 8 - 4 7 9 3
L A :
E n g l i s h
C S :
Hepatitis Viruses Section, Lab. Infectious Diseases, Natl. Inst. Allergy Infectious Diseases, Natl.
Inst. Health, Build. 7, Rm 200, 9000 Rockville Pike, Bethesda, MD 20892, USA
U T :
RESEARCH ARTICLE; HUMAN; INTERFERON-ALPHA-2A; ANTIVIRAL-DRUG; HORMONE-DRUG;
ALANINE AMINOTRANSFERASE; VIRAL RNA; POST-TREATMENT RELAPSE
I T :
ALFA-2A; ANTIVIRAL-DRUG; HORMONE-DRUG; INTERFERON-ALPHA-2A; POST-TREATMENT
R E L A P S E
S H :
(1) CHEMOTHERAPY-ANTIVIRAL AGENTS
S H :
(2) CLINICAL BIOCHEMISTRY-GENL METHODS,APPLICATIONS;
ENZYMES-PHYSIOLOGICAL STUDIES;
PATHOLOGY-INFLAMMATION,INFLAMMATORY DISEASE;
P A T H O L O G Y - T H E R A P Y ;
METABOLISM-PROTEINS,PEPTIDES,AMINO ACIDS;
METABOLISM-NUCLEIC ACIDS,PURINES,PYRIMIDINES;
DIGESTIVE SYSTEM-PATHOLOGY;
BLOOD & BODY FLUIDS-LYMPHATIC TISSUE,RES;
ENDOCRINE SYSTEM-GENERAL STUDIES;
PHARMACOLOGY-CLINICAL PHARMACOLOGY;
PHARMACOLOGY-DIGESTIVE SYSTEM;
PHARMACOLOGY-ENDOCRINE SYSTEM;
MEDICAL AND CLINICAL MICROBIOLOGY-VIROLOGY
S H :
(3) BIOCHEMICAL STUDIES-NUCLEIC ACIDS,PURINES,PYRIMIDINES;
BIOCHEMICAL STUDIES-PROTEINS,PEPTIDES,AMINO ACIDS;
BIOCHEMICAL STUDIES-CARBOHYDRATES;
BACTERIAL AND VIRAL GENETICS
B S :
Animal viruses-general (1993- ) ; Hominidae
A B :
Background and Methods. Chronic hepatitis D is a severe and rapidly progressive liver disease for
which no therapy has been proved effective. To evaluate the efficacy of treatment with interferon,
we studied 42 patients with chronic hepatitis D who were randomly assigned to receive either 9
million or 3 million units of recombinant interferon alfa-2a (three times a week for 48 weeks) or
no treatment. Results. By the end of the treatment period, serum alanine aminotransferase values
had become normal in 10 of 14 patients receiving 9 million units (71 percent), as compared with 4
of 14 treated with 3 million units (29 percent, P = 0.029) and 1 of 13 untreated controls (8 percent,
P = 0.001). Seven patients treated with the higher dose of interferon (50 percent) had a complete
response (normal levels of alanine aminotransferase and no detectable serum hepatitis delta virus
(HDV) RNA), as compared with three of those who received the lower dose (21 percent, P = 0.1 18),
and none of the controls (P = 0.004). Treatment with 9 million units of interferon was associated
with a marked improvement in the histologic findings (reduced periportal necrosis and portal
and lobular inflammation), whereas in the untreated controls there was considerable histologic
deterioration. In 5 of the 10 patients treated with 9 million units of interferon whose alanine
aminotransferase values became normal, the biochemical responses persisted for up to 4 years
(mean, 39 months), but the effects of treatment on viral replication were not sustained. In
contrast, none of those who received 3 million units and none of the untreated controls had a
sustained biochemical or virologic response. Conclusions. In about half the patients with chronic
hepatitis D treated with high doses of interferon alfa-2a (9 million units three times a week for
48 weeks), the serum alanine aminotransferase level becomes normal, HDV RNA becomes
undetectable in serum, and there is histologic improvement. However, a relapse is common
after treatment has been stopped.
S a m p l e R e c o r d s b y S e a r c h S y s t e m
2 9

<< Previous       1 .. 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37       Next >>



Other Documents:
H2 MED, H2 ZRCD, BIOSIS Previews workbook, bp brochure, ZR English, ZR CSA, ZRon SP, vendor chart bp, vendor chart zr, Declining Koala Pop ZR, BARRM Spanish, BA fact German, BAfact, BP Spanish, Ichthyology Flier, RRM fact German, ZR Spanish, ZR fact German, BIOSIS Previews Data Star, BIOSIS Previews WOK, BPDialog, ba ebsco, Col Soc Application, Collectors Society v 3 0, Newsletter 10.03, eeo 2004, prod Manual, prog App, August 2006 North TIERAwards, January 2006 North TIERAwards, January 2007 North TIERAwards, May 2007 North TIERAwards, NT RFP Guidelines Fall 07, Newsletter 08.04, Newsletter 10 04, Newsletter 12 04, Newsletter 2 05, Newsletter 09 07, Newsletter 10 05, Newsletter 11 07, Newsletter 12 05 1, Newsletter 9 05, registration instr, tiein consent, Shortz Guidelines 2008, Newsletter 8.03, mhz 2003schedule, Country Backgrounds, ESOL, English,


WODocs | |
All rights reserved. wodocs.com© 2009
WODocs


New Docs

Documents Category:
Arts (Design, Movies, Music, Radio, Television)
Automotive (Cars, Marine, Motorcycle, ATV, Snowmobiles)
Business (Biotechnology and Pharmaceuticals, Chemicals, Construction and Maintenance, Materials, Real Estate, Services)
Electronics (Computers, Motion Control, Power Supply)
Games (Board, Family, Party, Card, Construction, RC Toys)
Health (Animalm, Beauty, Healthcare, Medicine, Pharmacy, Surgery, Weight Loss)
Home (Accessories, Cooking, Decor and Design, Electrical, Family, Pets)
News (Newspapers, Sports, Television)
Recreation (Collecting, Hiking, Scouting, Survival, Travel)
Reference (Education, Libraries and Archives, Museums)
Science (Agriculture, Astronomy, Biology, Chemistry)
Shopping (Antiques and Collectibles, Clothing, Flowers, Food, Home and Garden)
Sports (Bicycle, Snowboard, Skiing, Other)